Canada· CA-DIN-02436531
FERRIPROX
A deferiprone product containing deferiprone, registered in Canada by CHIESI CANADA CORP.. The same ATC class is registered in 16 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Deferiprone is registered in 16 of 19 countries.
Countries holding a registration under ATC V03AC02 (deferiprone), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 10 of them publish a price we can compare per daily dose
Deferiprone · ATC V03AC02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of deferiprone costs, country by country.
Normalised to the WHO defined daily dose (5.25 g), the median price runs from $22.61 in Switzerland to $8636.08 in Italy — a ×382 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deferiprone · price per daily dose (5.25 g)
USD · FX 28 Sept 2026
- IT Italy$8636.08
- CH Switzerland$22.61
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- DEFERIPRONE
- Manufacturer
- CHIESI CANADA CORP.
- Country
- Canada (CA)
- ATC code
- V03AC02
- ATC class
- Deferiprone
- Defined daily dose
- 5.25 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
315 interactions on record for deferiprone.
Graded by severity as the source publishes them — 266 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deferiprone · interactions on record
315 records
- 266 severe
- 49 moderate
Most severe, free to view
- FostamatinibB02BX09severe
- ProcainamideC01BA02severe
- TocainideC01BB03severe
- PropylthiouracilH03BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Deferiprone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDeferiprone 500mg tabletsAdvanz Pharma
- United StatesDeferiproneAvKARE
- SpainFERRIPROX 500 mg COMPRIMIDOS CON CUBIERTA PELICULARChiesi Farmaceutici S.P.A.
- NetherlandsFerriprox, 500 mg filmomhulde tablettenChiesi Farmaceutici S.p.A.
- SwedenDeferipron Ebb 1000 mg Filmdragerad tablettEbb Medical AB
- FranceDEFERIPRONE ARROW 1000 mg, comprimé pelliculé sécableARROW GENERIQUES
- CzechiaDEFERIPRONE LIPOMEDLipomed GmbH, Weil am Rhein
- ItalyDEFERIPRONE DOCDOC GENERICI S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Cyprus · Deferiprone Sapiens
- Denmark · Deferipron Orifarm
- France · Deferiprone Arrow
- United Kingdom (Northern Ireland) · Deferiprone Mercury Pharmaceuticals, Deferiprone Mercury Pharmaceuticals Ltd.
- Greece · Befeprox
- Iceland · Ferriprox
- Italy · Deferiprone Doc
- Liechtenstein · Ferriprox
- Norway · Ferriprox
- Portugal · Befeprox, Deferriprona Generis
- Sweden · Deferipron Evolan, Deferiprone Doc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/60f6d2b2-b6e5-4266-931f-788c3f490e9a GET /v1/drugs/60f6d2b2-b6e5-4266-931f-788c3f490e9a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02436531",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V03AC02",
"schedule": [
"Prescription"
],
"drug_code": "92087",
"strengths": [
"500 MG"
],
"ahfs_class": null,
"substances": [
"DEFERIPRONE"
],
"product_categorization": null
}See everything about deferiprone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.